Equibles does not estimate personal net worth.
Get an email with a short summary when Krystal Biotech, Inc. publishes a filing, an earnings call transcript or a press release.
Get KRYS alertsKrish Krishnan is recorded as CEO at Krystal Biotech, Inc. (KRYS). Krish Krishnan has spoken on 10 earnings calls and 1 other investor event across 1 company, most recently for Krystal Biotech, Inc. on August 3, 2026. Krystal Biotech, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Krystal Biotech, Inc. includes Krish S. Krishnan (CEO and Board Member), Suma Krishnan (COO and Board Member), Suma M. Krishnan (COO) and 4 others.
“We were focused on execution in Q2, making solid progress across both our commercial and clinical programs. Internationally, strong underlying demand and high patient excitement underpin our launch.”
“Thanks, Alec. appreciate those comments the global launch which is XUS launch has exceeded our expectations today as you saw from the 1Q we've been able to make the drug and the team have been able to make a compelling value proposition both in France and in Germany and in Japan and were actually a bit ahead of…”
“It's now been 10 years since we founded CRYSTAL, and in that time, we have worked to change the lives of debt patients globally for the better. while building a durable, fully integrated company with the financial strength to continue delivering value for both patients and shareholders.”
“Before I begin, I want to recognize Sumer for being named to the Innovator List. the concept of enabling repeat dosing of a genetic medicine in a home setting by the patient is truly innovative so congrats suma stepping back i'm very pleased with where we are at crystal on the commercial side in 2025 we've made…”
“It gives me immense pride to realize that we're now in a position to help so many debt patients within and outside the U.S. I would like to thank the entire team at Crystal for their contributions.”
Biotechnology · Healthcare
CEO
